MOLECULAR DETERMINATION OF ERG11 GENE IN FLUCONAZOLE RESISTANT STRAINS OF CANDIDA TROPICALIS
Kavitha M. K.* and Arun B.
Abstract
Candidiasis is one of the most prevalent and important opportunistic
fungal infections, caused by Candida species. It is generally accepted
that suspected Candida infections can be treated with amphotericin B
(AmB), flucytosine, fluconazole, itraconazole, voriconazole and
echinocandins. But, a challenging area in the field of candidiasis
treatment is that the emergence of drug resistant Candida sp. is
increasingly being reported. Objectives of the study includes molecular
determination of drug resistant strains of Candida sp. The clinical
samples were obtained from patients having the symptoms of
candidiasis, attending the Obstetrics and Gynaecology Departments
and Dermatology and Venereology Departments of a Tertiary care
Hospital in North Kerala. Laboratory identification was performed and Antifungal Disk
Diffusion Susceptibility Testing was done with Antimicrobial Disks − Voriconazole (VRC 1
mcg/disc), Fluconazole (FLC 25 mcg/disc), Itraconazole (IT 10 mcg/disc) and Amphotericin
B (AP 100 units/disc) obtained from Himedia, Mumbai. Polymerase Chain Reaction (PCR)
was performed in an attempt for molecular characterization of the fluconazole resistant C.
tropicalis. During the study period, a total of 325 clinical samples were collected and 180
Candida isolates were obtained. Identification of fluconazole resistant ERG11 gene in
fluconazole resistant C. tropicalis by Real Time PCR resulted in 17 (48.6%) positive strains
and 18 (51.4%) negative strains out of a total of 35 fluconazole resistant isolates of C.
tropicalis. This study highlights the fact that there is a risk of emergence of azole resistant
strains of Non – Albicans Candida like C. tropicalis, which are increasingly being isolated
from clinical specimens.
Keywords: C. tropicalis, ERG11 gene, Fluconazole resistant, Real Time PCR.
[Full Text Article]